Cyclical dip masks execution risk on ₹3,500 Cr Tower 2

Delivered Q1 211.8 Cr; QoQ decline -15.8% matches narrative

Delivered YoY growth 9.5% revenue, 4% PAT — lower than claimed

FY26 revenue ₹1,031 Cr (+22% YoY), PAT ₹412 Cr (+10% YoY)

26 clients across both towers; rent range ₹150-210/sf; weighted avg ₹180/sf

Q1 PAT 100 Cr (+4.0% YoY), OPM 48.3%, NPM 39.1% — margins intact but growth weak

Prior AGM (FY25) cited 48-month timeline. Extension of 12 months adds execution risk; approval delays (IOD March 2025, commencement cert pending July 2026) are 12+ months behind plan.

FY26 realty ₹398 Cr (+8.6% YoY). Q1 realty growth not separately disclosed; implied flat/low given overall Q1 +9.5% but Exhibitions (+30%) and Foods (+107%) driving headline.

FY26 Exhibitions ₹260 Cr (+30% YoY), Foods ₹238 Cr (+107% YoY). Diversification away from cyclical realty gaining traction. 135 exhibition events in FY26.

Surrendered multiple sites due to regulatory issues, local unrest, infrastructure gaps. Only 4 sites remain under construction. Expected to commence operations by end FY27, but execution risk elevated.

Management declined to quantify FY27 revenue/margin targets. Long-term vision cited as 'enhancing growth, possible diversification,' but no CAGR or FY27/28 numbers.

Commencement cert timing is 60 mo from breaking ground. IOD delays attributed to regulatory. Management did not itemize missing clearances; deflected to 'future holds' approach.

Will compute escalation scenario post-call; details vary by contract (annual vs 3-year clauses). Most leases in force, no major exits envisaged.

No specific revenue mix or risk assessment provided. Chairman cited 5–6 year vision as 'enhancing growth, possible diversification,' but no numbers.

Cyclical business; Q4 typically strong, Q1 weak. Q1 YoY up almost 15% vs prior Q1, so underlying trend healthy.

Most funding via internal accruals; debt as last resort. Tower 2 ₹3,500 Cr, BEC Hall 1 ₹200 Cr, wayside amenities in progress.

Enhancing growth, maximizing in right direction, maybe diversification, but mainly top/bottom line growth.

Management stated cyclical pattern (Q1 weak, Q4 strong) but declined quantified FY27 target. Long-term vision generic: 'enhancing growth.'

Management reiterated focus on 'cost optimization, lean logistics' but no FY27 margin targets. Implication: margin pressure from capex absorption.

Funding via internal accruals; debt as backstop. CWIP ₹763 Cr as of March 2026. Management committed to no formal debt financing unless 'last-mile' requirement arises.

IOD received March 2025; commencement cert still pending July 2026 (12+ mo delay). 60-mo timeline starts from commencement cert, making Q1 FY31 + realistic completion. ₹3,500 Cr capex at risk if approvals stall further.

Multiple sites surrendered due to local villager unrest, infrastructure deficiencies, regulatory issues, handover conditions. ₹1.25–1.5 Cr project costs written off in Q1. Only 4 sites remain under construction; expected ops by end FY27, but execution credibility impaired.

Q1 PAT growth +4.0% YoY vs FY26 +10% YoY. As Tower 2 capex ramps, return on incremental capital uncertain. No profit guidance for FY27; dividend sustainability risk if capex absorbs cash flow.

26 clients across Towers 3&4 (13 each). Average rent ₹180/sf; no tenant >10% disclosed, but lease portfolio concentration not fully mapped. Rent escalation (annual vs 3-year clauses) varies; FY30 weighted avg rent projection withheld by management.

Indabrator reported lower FY26 revenue (₹35 Cr) due to softer demand in capital goods sectors (railways, defence, heavy engineering). Segment is small (3% of revenue) but sensitive to macro cycles.